126 related articles for article (PubMed ID: 9583491)
1. Critical role of phosphagens in the energy cascade of cutaneous ischemia and protective action of phosphocreatine analogues in skin flap survival.
Cuono CB; Marquetand R; Klein MB; Armitage I
Plast Reconstr Surg; 1998 May; 101(6):1597-603. PubMed ID: 9583491
[TBL] [Abstract][Full Text] [Related]
2. Analysis of high-energy phosphometabolites in delayed experimental skin flaps using 31P nuclear magnetic resonance spectroscopy.
Ha B; Park CG; Minn KW
Br J Plast Surg; 1997 Jun; 50(4):272-9. PubMed ID: 9215071
[TBL] [Abstract][Full Text] [Related]
3. Nuclear magnetic resonance spectroscopy of skin: predictive correlates for clinical application.
Cuono CB; Armitage IM; Marquetand R; Chapo GA
Plast Reconstr Surg; 1988 Jan; 81(1):1-11. PubMed ID: 3336625
[TBL] [Abstract][Full Text] [Related]
4. In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase.
Cui MH; Jayalakshmi K; Liu L; Guha C; Branch CA
NMR Biomed; 2015 Dec; 28(12):1634-44. PubMed ID: 26451872
[TBL] [Abstract][Full Text] [Related]
5. Relative abilities of phosphagens with different thermodynamic or kinetic properties to help sustain ATP and total adenylate pools in heart during ischemia.
Turner DM; Walker JB
Arch Biochem Biophys; 1985 May; 238(2):642-51. PubMed ID: 3994395
[TBL] [Abstract][Full Text] [Related]
6. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart.
Osbakken M; Ito K; Zhang D; Ponomarenko I; Ivanics T; Jahngen EG; Cohn M
Cardiology; 1992; 80(3-4):184-95. PubMed ID: 1511465
[TBL] [Abstract][Full Text] [Related]
7. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W
Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463
[TBL] [Abstract][Full Text] [Related]
8. Localized in vivo 31P NMR spectroscopy of skin flap metabolism.
Cheung A; Zhong J; Gore JC; Cuono CB
Magn Reson Med; 1994 Nov; 32(5):572-8. PubMed ID: 7808258
[TBL] [Abstract][Full Text] [Related]
9. Chronological observation on the energy metabolism of skin flaps by 31P-MRS: a novel approach to evaluate the state of a flap.
Kanno K; Hirakawa K
Plast Reconstr Surg; 1993 Feb; 91(2):322-8. PubMed ID: 8430148
[TBL] [Abstract][Full Text] [Related]
10. Enhanced ability of skeletal muscle containing cyclocreatine phosphate to sustain ATP levels during ischemia following beta-adrenergic stimulation.
Turner DM; Walker JB
J Biol Chem; 1987 May; 262(14):6605-9. PubMed ID: 3571272
[TBL] [Abstract][Full Text] [Related]
11. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
[TBL] [Abstract][Full Text] [Related]
12. Ischemic preconditioning improves the survival of skin and myocutaneous flaps in a rat model.
Zahir KS; Syed SA; Zink JR; Restifo RJ; Thomson JG
Plast Reconstr Surg; 1998 Jul; 102(1):140-50; discussion 151-2. PubMed ID: 9655419
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine).
Roberts JJ; Walker JB
Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340
[TBL] [Abstract][Full Text] [Related]
14. The use of P31 magnetic resonance spectroscopy to evaluate the effect of ATP-MgCl2 perfusion on the metabolism of rat skin island flaps.
Koh KS; Lee DG; Leem TW
Ann Plast Surg; 1997 Mar; 38(3):252-6. PubMed ID: 9088463
[TBL] [Abstract][Full Text] [Related]
15. Secondary ischemia caused by venous or arterial occlusion shows differential effects on myocutaneous island flap survival and muscle ATP levels.
Hauge EM; Balling E; Hartmund T; Hjortdal VE
Plast Reconstr Surg; 1997 Mar; 99(3):825-33. PubMed ID: 9047203
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of experimental skin flap survival via postoperative phosphocreatine replacement.
Cuono CB; Cortes A; Marquetand R; Weisberg V; Armitage IM
Surgery; 1987 Aug; 102(2):263-8. PubMed ID: 3303399
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Matthews RT; Yang L; Jenkins BG; Ferrante RJ; Rosen BR; Kaddurah-Daouk R; Beal MF
J Neurosci; 1998 Jan; 18(1):156-63. PubMed ID: 9412496
[TBL] [Abstract][Full Text] [Related]
18. Ischemic preconditioning by brief extremity ischemia before flap ischemia in a rat model.
Küntscher MV; Schirmbeck EU; Menke H; Klar E; Gebhard MM; Germann G
Plast Reconstr Surg; 2002 Jun; 109(7):2398-404. PubMed ID: 12045567
[TBL] [Abstract][Full Text] [Related]
19. Utilization of cyclocreatine phosphate, and analogue of creatine phosphate, by mouse brain during ischemia and its sparing action on brain energy reserves.
Woznicki DT; Walker JB
J Neurochem; 1980 May; 34(5):1247-53. PubMed ID: 7373304
[No Abstract] [Full Text] [Related]
20. The protective effect of L-arginine on ischemia-reperfusion injury in rat skin flaps.
Cordeiro PG; Mastorakos DP; Hu QY; Kirschner RE
Plast Reconstr Surg; 1997 Oct; 100(5):1227-33. PubMed ID: 9326784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
